James Kinley

James Kinley is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. In total, 8 filings cover trades dated from 1 December 2021 to 20 March 2025.

No open-market sale appears; the market trades are 2 purchases worth €2,245. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises.

On 25 March 2025 came the latest disclosure, an option exercise in Algernon Pharmaceuticals Inc. The most recent open-market purchase was published on 24 September 2024, 761 days ago. Typically, a trade is published a median of 5 days after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.